Bolsa de Madrid - Data of ORYZON GENOMICS, S.A.

03/07/2020 17:37:08
Bid			Ask
Orders	Volume	Price	Price	Volume	Orders
3	5,076	3.1800	3.1850	1,200	1
1	339	3.1750	3.1950	6,000	1
1	1,500	3.1700	3.2000	31,216	3
2	977	3.1600	3.2100	6,435	2
7	11,484	3.1500	3.2250	2,978	2

1 year
5 years

Last pay

Type	Ex-date	Payment Date	Concept

Last split

Date	Equivalence

Last reverse split

Date	Equivalence

Last capital increase

Period	Proportion	Type
30/06/2020	15 x 100	Premium

	2020 until 3/07	2019	2018	2017	2016
Capitalisation * (thousands of euros)	168,740	127,296	84,702	89,332	123,807
Shares (x 1,000)	53,063	45,790	39,123	34,161	28,468
Period Close Price (euros)	3.1800	2.7800	2.1650	2.6150	4.3490
Period Last Price (euros)	3.1800	2.7800	2.1650	2.6150	4.3490
Period High Price (euros)	3.8950	4.4650	5.1800	4.8330	5.2000
Period Low Price (euros)	1.4760	2.1150	2.0450	1.7500	2.5500
Volume (thousands of shares)	59,114	78,113	95,258	34,979	9,948
Turnover (thousands of euros)	184,049	260,089	336,854	99,399	41,220

Profile

Founded in 2000 in Barcelona, Spain, Oryzon is a clinical stage biopharmaceutical company considered as the European champion in Epigenetics. Oryzon has one of the strongest portfolios in the field. Oryzon’s LSD1 program has rendered two compounds Vafidemstat and Iadademstat in Phase II clinical trials. In addition, Oryzon has ongoing programs for developing inhibitors against other epigenetic targets. Oryzon has a strong technological platform for biomarker identification and performs biomarker and target validation for a variety of malignant and neurodegenerative diseases. Oryzon has offices in Spain and the United States.

For more information, visit www.oryzon.com

Source: Issuing company.

05/07/2020 00:00:36

Research

Morningstar - Quantitative Report (5 July 2020 08:15) (64 KB)

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.